Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... de réir Kala Visvanathan (14952973)

Rannpháirtithe:

Supplementary Figure S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... de réir Kala Visvanathan (14952973)

Rannpháirtithe:

Supplementary Figure S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... de réir Kala Visvanathan (14952973)

Rannpháirtithe:

Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... de réir Kala Visvanathan (14952973)

Rannpháirtithe:

Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... de réir Kala Visvanathan (14952973)

Rannpháirtithe:

Figure S2 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer de réir Jamunarani Veeraraghavan (16461809)

Rannpháirtithe:

Supplementary Tables 1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Canc... de réir Jamunarani Veeraraghavan (16461809)

Rannpháirtithe:

Figure S4 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer de réir Jamunarani Veeraraghavan (16461809)

Rannpháirtithe:

Figure S5 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer de réir Jamunarani Veeraraghavan (16461809)

Rannpháirtithe:

Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer de réir Jamunarani Veeraraghavan (16461809)

Rannpháirtithe:

Figure S1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer de réir Jamunarani Veeraraghavan (16461809)

Rannpháirtithe:

Figure S3 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer de réir Jamunarani Veeraraghavan (16461809)

Rannpháirtithe: